| | Publication Year | Title | Author(s) |
| 501 | 16-Aug-2013 | Targeting the ERBB family in cancer: couples therapy. | Tebbutt, Niall C ; Pedersen, Mikkel W; Johns, Terrance G |
| 502 | 12-Oct-2016 | Targeting the vasculature: anti-angiogenic agents for malignant mesothelioma | Chia, Puey Ling ; Russell, Prudence A; Scott, Andrew M ; John, Thomas |
| 503 | Apr-2023 | Taxane-induced neuropathy: How serious is this problem for patients with early breast cancer? | Nicolae, Robert; Uccellini, Anthony; Siderov, Jim ; Mellerick, Angela ; Wong, Vanessa ; Yeo, Belinda |
| 504 | 9-Dec-2013 | Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. | Butts, Charles; Socinski, Mark A; Mitchell, Paul L R ; Thatcher, Nick; Havel, Libor; Krzakowski, Maciej; Nawrocki, Sergiusz; Ciuleanu, Tudor-Eliade; Bosquée, Lionel; Trigo, José Manuel; Spira, Alexander; Tremblay, Lise; Nyman, Jan; Ramlau, Rodryg; Wickart-Johansson, Gun; Ellis, Peter; Gladkov, Oleg; Pereira, José Rodrigues; Eberhardt, Wilfried Ernst Erich; Helwig, Christoph; Schröder, Andreas; Shepherd, Frances A |
| 505 | Jun-2015 | Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses. | Mitchell, Paul L R ; Thatcher, N; Socinski, M A; Wasilewska-Tesluk, E; Horwood, K; Szczesna, A; Martín, C; Ragulin, Y; Zukin, M; Helwig, C; Falk, M; Butts, C; Shepherd, F A |
| 506 | Jul-2023 | Technique for pudendal nerve block in proctology - a video vignette. | Watson, Eleanor G R; Shearer, Nicholas J W; Smart, Philip J ; Burgess, Adele N ; Proud, David M; Mohan, Helen M |
| 507 | Nov-2016 | Temozolomide-associated liver fibrosis | Parakh, Sagun ; Hamid, Anis A; Cher, Lawrence M ; Gan, Hui K |
| 508 | Aug-2016 | Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatment | Chia, Puey Ling ; Do, Hongdo; Morey, Adrienne; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas |
| 509 | Apr-2018 | The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression. | Yeo, Belinda ; Redfern, Andrew D; Mouchemore, Kellie A; Hamilton, John A; Anderson, Robin L |
| 510 | Nov-2018 | The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression. | Ren, Shengxiang; Tian, Qinrui; Amar, Nadav; Yu, Hui; Rivard, Christopher J; Caldwell, Charles; Ng, Terry L; Tu, Megan; Liu, Yiwei; Gao, Dexiang; Ellison, Kim; Suda, Kenichi; Rozeboom, Leslie; Rivalland, Gareth; Mitchell, Paul L R ; Zhou, Caicun; Hirsch, Fred R |
| 511 | 24-Oct-2017 | The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. | Ghaneh, Paula; Kleeff, Jorg; Halloran, Christopher M; Raraty, Michael; Jackson, Richard; Melling, James; Jones, Owain; Palmer, Daniel H; Cox, Trevor F; Smith, Chloe J; O'Reilly, Derek A; Izbicki, Jakob R; Scarfe, Andrew G; Valle, Juan W; McDonald, Alexander C; Carter, Ross; Tebbutt, Niall C ; Goldstein, David; Padbury, Robert; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Anthoney, Alan; Lerch, Markus M; Mayerle, Julia; Oláh, Attila; Rawcliffe, Charlotte L; Campbell, Fiona; Strobel, Oliver; Büchler, Markus W; Neoptolemos, John P |
| 512 | 2019 | The Impact of Universal Immunohistochemistry on Lynch Syndrome Diagnosis in an Australian Colorectal Cancer Cohort. | Loh, Zoe ; Williams, David S ; Salmon, Lucinda ; Dow, Eryn; John, Thomas |
| 513 | 21-Jul-2018 | The LEAD study protocol: a mixed-method cohort study evaluating the lung cancer diagnostic and pre-treatment pathways of patients from Culturally and Linguistically Diverse (CALD) backgrounds compared to patients from Anglo-Australian backgrounds. | Mazza, Danielle; Lin, Xiaoping; Walter, Fiona M; Young, Jane M; Barnes, David J; Mitchell, Paul L R ; Brijnath, Bianca; Martin, Andrew; Emery, Jon D |
| 514 | 2020 | The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT]. | Clarke, Stephen John; Burge, Matthew; Feeney, Kynan; Gibbs, Peter; Jones, Kristian; Marx, Gavin; Molloy, Mark P; Price, Timothy; Reece, William H H; Segelov, Eva; Tebbutt, Niall C |
| 515 | 15-Sep-2017 | The role of early magnetic resonance imaging in predicting survival on bevacizumab for recurrent glioblastoma: Results from a prospective clinical trial (CABARET). | Field, Kathryn M; Phal, Pramit M; Fitt, Gregory J ; Goh, Christine; Nowak, Anna K; Rosenthal, Mark A; Simes, John; Barnes, Elizabeth H; Sawkins, Kate; Cher, Lawrence M ; Hovey, Elizabeth J; Wheeler, Helen |
| 516 | Aug-2019 | The Victorian Comprehensive Cancer Centre lung cancer clinical audit: collecting the UK National Lung Cancer Audit data from hospitals in Australia. | Mileshkin, Linda; Dunn, Catherine; Cross, Hannah; Duffy, Mary; Shaw, Mark; Antippa, Phillip; Mitchell, Paul L R ; Akhurst, Tim; Conron, Matthew; Moore, Melissa; Philip, Jenny; Bartlett, James; Emery, Jon; Zambello, Belinda |
| 517 | 19-Mar-2020 | Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients with Elevated CEA. | Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; De Gramont, Aimery; Shi, Qian; Overman, Michael James |
| 518 | 1-Nov-2020 | Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA. | Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; Gramont, Aimery De; Shi, Qian; Overman, Michael James |
| 519 | 2023 | Thymic Carcinoid in a Patient with Concurrent Manifestations of Multiple Endocrine Neoplasia Type 1. | Zhu, Jasmine J ; Dean, Samantha; Hafeez, Umbreen ; Neoh, Sandra L |
| 520 | Apr-2020 | Tracking Drug-Induced Epithelial-Mesenchymal Transition in Breast Cancer by a Microfluidic Surface-Enhanced Raman Spectroscopy Immunoassay. | Zhang, Zhen; Wang, Jing; Shanmugasundaram, Karthik Balaji; Yeo, Belinda ; Möller, Andreas; Wuethrich, Alain; Lin, Lynlee L; Trau, Matt |